The use of chemotherapy in patients with localized high-grade soft tissue sarcoma (STS) is still under discussion in the sarcoma community. Outside clinical trials, the systemic treatment must be applied on the basis of a patient–physician shared decision [1]. Several studies have been performed with conflicting results, but in two meta-analysis an advantage from the use of chemotherapy has been showed in patients with high-grade, large (>5 cm) and deep seated STS [2, 3].
Ferrari S., Palmerini E. (2019). Chemotherapy of Soft Tissue Sarcomas. Switzerland : Springer International Publishing [10.1007/978-3-030-29676-6_48].
Chemotherapy of Soft Tissue Sarcomas
Palmerini E.
Writing – Original Draft Preparation
2019
Abstract
The use of chemotherapy in patients with localized high-grade soft tissue sarcoma (STS) is still under discussion in the sarcoma community. Outside clinical trials, the systemic treatment must be applied on the basis of a patient–physician shared decision [1]. Several studies have been performed with conflicting results, but in two meta-analysis an advantage from the use of chemotherapy has been showed in patients with high-grade, large (>5 cm) and deep seated STS [2, 3].File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
